Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.
Brunzell
John D
JD
Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, and the Northwest Lipid Laboratory, University of Washington, Seattle, Washington, USA.
Davidson
Michael
M
Furberg
Curt D
CD
Goldberg
Ronald B
RB
Howard
Barbara V
BV
Stein
James H
JH
Witztum
Joseph L
JL
D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000378:metabolism; D012307:Risk Factors; D012955:Societies, Medical; D014481:United States; D014837:Voluntary Health Agencies
D008078:Cholesterol, LDL; D008074:Lipoproteins